Towa Pharmaceutical Co., Ltd. (TYO:4553)
Japan
· Delayed Price · Currency is JPY 3,100.00
-25.00 (-0.80%)
Jun 9, 2025, 3:30 PM JST
Towa Pharmaceutical Revenue
In the fiscal year ending March 31, 2025, Towa Pharmaceutical had annual revenue of 259.59B JPY with 13.89% growth. Towa Pharmaceutical had revenue of 65.86B in the quarter ending March 31, 2025, with 10.48% growth.
Revenue
259.59B
Revenue Growth
+13.89%
P/S Ratio
0.59
Revenue / Employee
56.58M
Employees
4,588
Market Cap
153.83B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 259.59B | 31.66B | 13.89% |
| Mar 31, 2024 | 227.93B | 19.08B | 9.13% |
| Mar 31, 2023 | 208.86B | 43.24B | 26.11% |
| Mar 31, 2022 | 165.62B | 10.72B | 6.92% |
| Mar 31, 2021 | 154.90B | 44.52B | 40.33% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Takeda Pharmaceutical Company | 4,581.55B |
| Daiichi Sankyo Company | 1,886.26B |
| HOYA Corporation | 869.37B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 997.33B |